158 related articles for article (PubMed ID: 316328)
1. Danazol's failure to suppress autoimmunity in NZB/NZW F1 mice.
Roubinian JR; Talal N; Greenspan JS; Goodman JR; Nussenzweig V
Arthritis Rheum; 1979 Dec; 22(12):1399-1402. PubMed ID: 316328
[No Abstract] [Full Text] [Related]
2. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
Gunn HC
Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic studies in New Zealand mice. VII. Successful androgen treatment of NZB/NZW F1 females of different ages.
Melez KA; Boegel WA; Steinberg AD
Arthritis Rheum; 1980 Jan; 23(1):41-7. PubMed ID: 7352943
[No Abstract] [Full Text] [Related]
4. Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement.
Agnello V; Pariser K; Gell J; Gelfand J; Turksoy RN
J Rheumatol; 1983 Oct; 10(5):682-7. PubMed ID: 6606038
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice.
Hirose S; Tokushige K; Kinoshita K; Nozawa S; Saito J; Nishimura H; Shirai T
Eur J Immunol; 1991 Mar; 21(3):823-6. PubMed ID: 1826267
[TBL] [Abstract][Full Text] [Related]
6. [Danazol and autoimmune thrombocytopenia in systemic lupus erythematosus].
Selva A; Jordana R; Tolosa C; Ordi J
Med Clin (Barc); 1990 Apr; 94(14):557-8. PubMed ID: 2355774
[No Abstract] [Full Text] [Related]
7. [The effect of inducers of endogenous interferon on the course of an autoimmune process in F1 inbred NZB/NZW mice].
Nasonova VA; Balabanova RM; Pleskovskaia GN; Venikova MS; Poverennyĭ AM; Podgorodnichenko VK; Popova GA
Vopr Virusol; 1990; 35(5):408-11. PubMed ID: 2267785
[No Abstract] [Full Text] [Related]
8. Danazol for Evan's syndrome due to SLE.
Aranegui P; Giner P; Lopez-Gomez M; el Amrani A; Jimenez-Alonso J
DICP; 1990 Jun; 24(6):641-2. PubMed ID: 2360344
[No Abstract] [Full Text] [Related]
9. Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
Mozes E; Zinger H; Kohn LD; Singer DS
J Clin Immunol; 1998 Mar; 18(2):106-13. PubMed ID: 9533654
[TBL] [Abstract][Full Text] [Related]
10. The effect of danazol in the MRL/lpr mouse model of autoimmune disease.
Connolly KM; Stecher VJ; Snyder BW; Bohnet E; Potts GO
Agents Actions; 1988 Aug; 25(1-2):164-70. PubMed ID: 3189043
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin: efficacy in the treatment of murine autoimmune disease.
Klassen LW; Budman DR; Williams GW; Steinberg AD; Gerber NL
Science; 1977 Feb; 195(4280):787-9. PubMed ID: 299957
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
McMurray RW; Elbourne KB; Lagoo A; Lal S
J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
[TBL] [Abstract][Full Text] [Related]
14. Study of thymic factors. II. Failure of thymosin to alter the natural history of NZB and NZB/NZW mice.
Gershwin ME; Steinberg AD; Ahmed A; Derkay C
Arthritis Rheum; 1976; 19(5):862-6. PubMed ID: 1085626
[TBL] [Abstract][Full Text] [Related]
15. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
16. DNAse treatment does not improve the survival of lupus prone (NZB x NZW)F1 mice.
Verthelyi D; Dybdal N; Elias KA; Klinman DM
Lupus; 1998; 7(4):223-30. PubMed ID: 9643311
[TBL] [Abstract][Full Text] [Related]
17. Reversal of lupus-erythematosus-like disease with danazol.
Masse R; Youinou P; Dorval JC; Cledes J
Lancet; 1980 Sep; 2(8195 pt 1):651. PubMed ID: 6107447
[No Abstract] [Full Text] [Related]
18. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
19. Effect of danazol on lupus-erythematosus-like disease in hereditary angioneurotic oedema.
Donaldson VH; Hess EV
Lancet; 1980 Nov; 2(8204):1145. PubMed ID: 6107762
[No Abstract] [Full Text] [Related]
20. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
